Transcriptomics

Dataset Information

61

Expression data of multiple sclerosis patients receiving subcutaneous Interferon-beta-1b therapy [U133 A and B]


ABSTRACT: The purpose of this study was to characterize the transcriptional effects induced by subcutaneous IFN-beta-1b treatment (Betaferon, 250 µg every other day) in patients with relapsing-remitting form of multiple sclerosis (MS). By using Affymetrix DNA microarrays, we obtained genome-wide expression profiles of peripheral blood mononuclear cells from 25 MS patients within the first two years of IFN-beta administration. Overall design: EDTA blood samples were drawn from all patients immediately before first, second, month 1, 12, and 24 IFN-beta injection. Total RNA of Ficoll-isolated peripheral blood mononuclear cells from each sample was extracted, labeled and hybridized to Affymetrix Human Genome U133 A and B arrays to quantify the mRNA levels.

INSTRUMENT(S): [HG-U133A] Affymetrix Human Genome U133A Array

ORGANISM(S): Homo sapiens  

SUBMITTER: Robert Goertsches  

PROVIDER: GSE24427 | GEO | 2010-09-29

SECONDARY ACCESSION(S): PRJNA132617

REPOSITORIES: GEO

Similar Datasets

2009-12-03 | GSE19285 | GEO
2011-12-06 | E-GEOD-33464 | ArrayExpress
2010-05-19 | E-GEOD-19285 | ArrayExpress
2010-09-29 | E-GEOD-24427 | ArrayExpress
2013-04-24 | E-GEOD-46282 | ArrayExpress
2013-04-24 | E-GEOD-46280 | ArrayExpress
| GSE46292 | GEO
| GSE46283 | GEO
2006-08-23 | GSE5574 | GEO
2011-06-01 | GSE26484 | GEO